Access to innovation through the French Expanded-Access Program and clinical trials in patients with malignant melanoma.

被引：0
|
作者：
Christen, Claire
Belgodere, Laetitia
Guillot, Bernard
Kerouani-Lafaye, Ghania
Brunel, Liora
Turcry, Florence
Monard, Adrien
Grude, Francoise
Guyader, Gaelle
Boudali, Lotfi
Albin, Nicolas
机构：
[1] French Natl Agcy Med & Hlth Prod Safety ANSM, St Denis, France
[2] CHU Montpellier, Univ Hosp Montpellier, Dermatol Dept, Montpellier, France
[3] Grp Hosp Mutualiste Grenoble, Grenoble, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22030
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Access to innovation through the national early access program and clinical trials for patients with malignant melanoma
    Christen, Claire
    Belgodere, Laetitia
    Guillot, Bernard
    Jumeau, Celine
    Lorence, Annie
    Kerouani-Lafaye, Ghania
    Brunel, Liora
    Turcry, Florence
    Monard, Adrien
    Grude, Francoise
    Guyader, Gaelle
    Boudali, Lotfi
    Albin, Nicolas
    CANCER, 2021, 127 (13) : 2262 - 2270
  • [2] Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma
    Hogg, D.
    Monzon, J. G.
    Ernst, S.
    Song, X.
    McWhirter, E.
    Savage, K. J.
    Skinn, B.
    Romeyer, F.
    Smylie, M.
    CURRENT ONCOLOGY, 2020, 27 (04) : 204 - 214
  • [3] Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab
    Jacquet, Emmanuelle
    Pham, Fiona
    Taouk, Billy
    Kerouani-Lafaye, Ghania
    Monard, Adrien
    Brunel, Liora
    Albin, Nicolas
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (03) : 223 - 228
  • [4] Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab
    Emmanuelle Jacquet
    Fiona Pham
    Billy Taouk
    Ghania Kerouani-Lafaye
    Adrien Monard
    Liora Brunel
    Nicolas Albin
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 223 - 228
  • [5] Baseline Characteristics of Patients With Fabry Disease Enrolled in the Pegunigalsidase Alfa Expanded-Access Program
    Mehta, Ankit
    Wilcox, William
    Nedd, Khan J.
    Bernat, John A.
    Knoll, Jasmine
    Jefferies, John L.
    Longo, Nicola
    Wallace, Eric L.
    Almon, Einat
    Alon, Sari
    Chertkoff, Raul
    Sullivan, Dawn
    Rocco, Rossana
    Koulinska, Irene
    Goker-Alpan, Ozlem
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 417 - 417
  • [6] EXPANDED-ACCESS PROGRAM (EAP) OF SUNITINIB IN 458 PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Sternberg, C. N.
    Porta, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Conte, P.
    Monfardini, S.
    Gasparini, G.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 194 - 194
  • [7] National Early Access Programs and Clinical Trials: What Opportunities for Early Access to Therapeutic Innovations for Patients With Malignant Melanoma?
    Kempf, Emmanuelle
    Zalcman, Gerard
    Lebbe, Celeste
    CANCER, 2021, 127 (13) : 2181 - 2183
  • [8] Efficacy of nivolumab and ipilimumab (Nivo plus Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP).
    Shoushtari, Alexander Noor
    Navid-Azarbaijani, Pedram
    Friedman, Claire Frances
    Panageas, Katherine
    Postow, Michael Andrew
    Callahan, Margaret K.
    Momtaz, Parisa
    Campbell, Shonnette C.
    Shames, Yelena
    Prempeh-Keteku, Nana A.
    Nwaedozie, Kasiemobi
    Wolchok, Jedd D.
    Chapman, Paul B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Obtaining i.v. fosfomycin through an expanded-access protocol
    Frederick, Corey M.
    Burnette, Jennifer
    Aragon, Laura
    Gauthier, Timothy P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (16) : 1250 - 1253
  • [10] Pazopanib in soft tissue sarcoma: Experience from a UK expanded-access program
    Frezza, Anna Maria
    Benson, Charlotte
    Miah, Aisha
    Linch, Mark David
    Alvarado, Rolyn
    Mitchell, Scott
    Esler, Claire
    Hatcher, Helen
    Judson, Ian Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345